INS and diabetes mellitus: While this LC-MS/MS assay for proinsulin proteoforms needs additional optimization, validation, and cross-lab assessment for transferability, it is anticipated that this assay will have broad utility in diabetes clinical studies, especially T1D, focusing on disease progression or therapeutic interventions.